Squamous cell carcinoma accounts for approximately 95% of all penile cancers.

HPV infection, particularly certain high-risk strains, is the primary risk factor for penile cancer.

A painless lump or ulcer on the penis is the most common initial symptom of penile cancer.

Penile cancer typically occurs on the glans penis, prepuce, or shaft of the penis, but not the scrotum.

Surgery is the primary treatment for early-stage penile cancer, aiming to remove the cancerous tissue.

Advanced-stage penile cancer often requires a combination of treatments, including surgery, radiation therapy, and chemotherapy.

Heart disease is not a common complication of penile cancer treatment.

Regular follow-up care after penile cancer treatment typically includes physical examinations, imaging tests, and blood tests to monitor for recurrence or complications.

The 5-year survival rate for penile cancer is generally high, with approximately 90-95% of patients surviving for at least 5 years after diagnosis.

Smoking cessation is not a direct preventive measure for penile cancer, although it can improve overall health.

HPV vaccination is recommended for boys and girls at the age of 11-12 years to prevent HPV-related cancers, including penile cancer.

Itching or burning sensation on the penis is not a common symptom of penile cancer.

Follow-up care after penile cancer treatment is typically recommended every 3 months for the first year, then every 6 months for the next 4 years.

Hair loss is not a common side effect of radiation therapy for penile cancer.